Building a transparent, data-driven supply chain and self-reliant API ecosystem remains critical to reducing import dependence
PET sheets are widely recognised for their superior clarity, strength, and barrier properties
Capvaxive has recorded $530 million in cumulative sales over its first four quarters on the market
Sotyktu continues to demonstrate consistent efficacy and safety across rheumatic conditions
Sigachi Industries has reported total income of Rs. 112.97 crore during the period ended September 30, 2025
Long-term OGSIVEO treatment for up to four years associated with further tumor reductions, increased objective response rate, sustained symptom improvement, and consistent safety profile
Global Phase 3 MANEUVER study highlights ongoing benefits and consistent safety profile
Results from the Phase 2 PHAROS trial potentially establish new benchmark with targeted combination therapies for this patient population
This new suite of products demonstrates Nouryon’s leadership in cleaning ingredient solutions
Speakers for the Session are: Venkata Prasad K., Unit Head, Deepak Nitrite; Abhilash Pasham, Associate General Manager - Central Engineering & Projects, Dr. Reddy's Laboratories; C. V. Rajulu, Consultant, Industry; and Jyoti Shankar Jha, Senior Lead Scientist, Alleima India. The moderator for the Session is Pravin Prashant, Executive Editor, Indian Pharma Post
Subscribe To Our Newsletter & Stay Updated
